1 |
1) inosine 5'-monophosphate |
Inosine |
[1] D00054 D00054 💬 |
- |
- |
017 [1] 17 💬 |
2 |
1-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one |
- |
- |
- |
- |
017 [1] 17 💬 |
3 |
11c-methylreboxetine |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
4 |
13n-ammonia |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
006 [2] 6 , 17 💬 |
5 |
18f-dopa |
- |
- |
- |
- |
006 [3] 6 , 17, 75 💬 |
6 |
18f-dopamne |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
7 |
[18f]fdopa |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
8 |
[f-18]pbr06 |
- |
- |
- |
- |
013 [2] 13, 17 💬 |
9 |
Adjuvant without active component |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
10 |
Affitope® pd01a + adjuvant |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
11 |
Affitope® pd03a + adjuvant |
- |
- |
- |
- |
017 [1] 17 💬 |
12 |
Ammonia |
Ammonia |
[1] D02916 D02916 💬 |
- |
- |
006 [4] 6 , 17, 86, 88 💬 |
13 |
Ampreloxetine |
Ampreloxetine |
[1] D11688 D11688 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 17 💬 |
14 |
Ampreloxetine chydrochloride |
Ampreloxetine |
[1] D11688 D11688 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 17 💬 |
15 |
Ampreloxetine hydrochloride |
Ampreloxetine |
[1] D11688 D11688 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 17 💬 |
16 |
Angiotensin |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [7] 17, 19, 46, 66, 86, 222, 224 💬 |
17 |
Angiotensin-(1-7) |
Angiotensin II |
[2] D00150 D00150, D02014 D02014 💬 |
AGTR1 [2] AGTR1, AGTR2 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
18 |
Anti-parkinson medication |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 8 , 17 💬 |
19 |
Atomexetine |
- |
- |
- |
- |
017 [1] 17 💬 |
20 |
Autologous mesenchymal stem cells |
- |
- |
- |
- |
002 [5] 2 , 6 , 13, 17, 46 💬 |
21 |
Azd3241 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
22 |
Azd3241 100mg |
- |
- |
- |
- |
017 [1] 17 💬 |
23 |
Azd3241 300mg |
- |
- |
- |
- |
017 [1] 17 💬 |
24 |
Azilect |
- |
- |
- |
- |
002 [4] 2 , 5 , 6 , 17 💬 |
25 |
Azilect 1 mg comprimidos |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
26 |
Behavioral: bci-fit active querying |
- |
- |
- |
- |
002 [3] 2 , 6 , 17 💬 |
27 |
Behavioral: bci-fit adaptive signal modeling |
- |
- |
- |
- |
002 [3] 2 , 6 , 17 💬 |
28 |
Behavioral: bci-fit language modeling |
- |
- |
- |
- |
002 [3] 2 , 6 , 17 💬 |
29 |
Behavioral: bci-fit multi-modal access |
- |
- |
- |
- |
002 [3] 2 , 6 , 17 💬 |
30 |
Behavioral: clinical characteristics of ams patients |
- |
- |
- |
- |
017 [1] 17 💬 |
31 |
Behavioral: conservative measures for orthostatic hypotension |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
32 |
Behavioral: montreal cognitive assessment (moca) |
- |
- |
- |
- |
017 [1] 17 💬 |
33 |
Bhv-3241 |
- |
- |
- |
- |
017 [1] 17 💬 |
34 |
Bhv-4157 |
- |
- |
- |
- |
017 [1] 17 💬 |
35 |
Biib101 |
- |
- |
- |
- |
017 [1] 17 💬 |
36 |
Blood sampling |
- |
- |
- |
- |
013 [5] 13, 17, 19, 51, 96 💬 |
37 |
Botulinum toxin type a |
Botulinum toxin type A |
[1] D00783 D00783 💬 |
SNAP25 [1] SNAP25 💬 |
Insulin secretion [2] Insulin secretion, Synaptic vesicle cycle |
002 [10] 2 , 5 , 6 , 7 , 13, 15, 17, 70, 113, 149 💬 |
38 |
Bq123 |
- |
- |
- |
- |
017 [1] 17 💬 |
39 |
Bydureon |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
40 |
Captopril |
Captopril |
[1] D00251 D00251 💬 |
ACE [1] ACE 💬 |
Chagas disease [6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system |
017 [2] 17, 86 💬 |
41 |
Carbidopa |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [9] 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬 |
42 |
Carbidopa 200mg oral dose |
Carbidopa |
[1] D00558 D00558 💬 |
DDC [1] DDC 💬 |
Alcoholism [9] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
43 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 [12] 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
44 |
Cs10br05 |
- |
- |
- |
- |
017 [1] 17 💬 |
45 |
Datscan |
- |
- |
- |
- |
002 [4] 2 , 5 , 6 , 17 💬 |
46 |
Datscan™ ioflupane (123i) injection |
- |
- |
- |
- |
005 [3] 5 , 6 , 17 💬 |
47 |
Desipramine |
Desipramine |
[2] D00812 D00812, D07791 D07791 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [4] 6 , 17, 120, 156 💬 |
48 |
Desipramine (dmi) |
Desipramine |
[2] D00812 D00812, D07791 D07791 💬 |
SLC6A2 [2] SLC6A2, SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
006 [2] 6 , 17 💬 |
49 |
Device: abdominal compression |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
50 |
Device: deep brain stimulation |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 8 , 17 💬 |
51 |
Device: sham compression |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
52 |
Diagnostic test: [18f]-ro6958948 |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
53 |
Diagnostic test: elecsys (roche) abeta42, ttau and ptau |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
54 |
Diagnostic test: flutemetamol f18 injection |
Flutemetamol |
[1] D10231 D10231 💬 |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
55 |
Diagnostic test: lumipulse (fujirebio) abeta42, ttau and ptau |
- |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
56 |
Dmi |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
57 |
Domperidone |
Domperidone |
[2] D01745 D01745, D07868 D07868 💬 |
DRD2 [1] DRD2 💬 |
Alcoholism [8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
006 [5] 6 , 13, 17, 51, 230 💬 |
58 |
Dops |
Droxidopa |
[1] D01277 D01277 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
006 [2] 6 , 17 💬 |
59 |
Droxidopa |
Droxidopa |
[1] D01277 D01277 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
005 [3] 5 , 6 , 17 💬 |
60 |
Egcg |
Epigallocatechin gallate |
- |
- |
- |
006 [9] 6 , 8 , 13, 17, 28, 85, 113, 206, 299 💬 |
61 |
Egcg as putative neuroprotective agent |
Epigallocatechin gallate |
- |
- |
- |
017 [1] 17 💬 |
62 |
Emeramide |
Emeramide |
- |
- |
- |
005 [2] 5 , 17 💬 |
63 |
Entacapone |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
64 |
Entacapone 400mg oral dose |
Entacapone |
[1] D00781 D00781 💬 |
COMT [1] COMT 💬 |
Dopaminergic synapse [4] Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
65 |
Exenatide |
Exenatide |
[1] D04121 D04121 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
006 [4] 6 , 17, 193, 233 💬 |
66 |
Exenatide pen injector [bydureon] |
Exenatide |
[1] D04121 D04121 💬 |
GLP1R [1] GLP1R 💬 |
Insulin secretion [3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
017 [1] 17 💬 |
67 |
Fipamezole |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
68 |
Fipamezole hydrochloride |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
69 |
Fipamezole hydrochloride 30 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
70 |
Fipamezole hydrochloride 60 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
71 |
Fipamezole hydrochloride 90 mg oral disintegrating tablets |
Fipamezole |
- |
- |
- |
006 [2] 6 , 17 💬 |
72 |
Fludrocortisone |
Fludrocortisone |
[2] D00986 D00986, D07967 D07967 💬 |
NR3C2 [1] NR3C2 💬 |
Aldosterone-regulated sodium reabsorption [1] Aldosterone-regulated sodium reabsorption |
006 [3] 6 , 17, 81 💬 |
73 |
Flumazenil |
Flumazenil |
[1] D00697 D00697 💬 |
GABRA1 [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [5] 6 , 13, 17, 18, 206 💬 |
74 |
Fluoxetine |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
013 [4] 13, 17, 78, 86 💬 |
75 |
Fluoxétine |
Fluoxetine |
[2] D00326 D00326, D00823 D00823 💬 |
SLC6A4 [1] SLC6A4 💬 |
Serotonergic synapse [2] Serotonergic synapse, Synaptic vesicle cycle |
017 [1] 17 💬 |
76 |
Flutemetamol |
Flutemetamol |
- |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
77 |
Flutemetamol f18 |
Flutemetamol |
[1] D10231 D10231 💬 |
- |
- |
005 [5] 5 , 6 , 7 , 17, 127 💬 |
78 |
Gold |
Gold |
- |
- |
- |
002 [38] 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
79 |
Green tea |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
006 [5] 6 , 17, 28, 46, 96 💬 |
80 |
Green tea leaf |
Green tea leaf |
[1] D06903 D06903 💬 |
- |
- |
017 [1] 17 💬 |
81 |
Homeostasis model assessment of insulin resistance (homa) |
- |
- |
- |
- |
017 [1] 17 💬 |
82 |
Hydrogen |
Hydrogen |
- |
- |
- |
005 [7] 5 , 6 , 13, 17, 83, 97, 226 💬 |
83 |
Inosine |
Inosine |
[1] D00054 D00054 💬 |
- |
- |
002 [4] 2 , 6 , 13, 17 💬 |
84 |
Intranasal insulin |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
85 |
Intravenous immunoglobulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
014 [4] 14, 17, 164, 296 💬 |
86 |
Intravesical injection of botulinum a toxin |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
87 |
Iupac name: 1-(2-isopropoxyethyl)-2-thioxo-1,2,3,5-tetrahydro-pyrrolo[3,2-d] pyrimidin-4-one |
- |
- |
- |
- |
017 [1] 17 💬 |
88 |
Ivig |
Human immunoglobulin G |
- |
- |
- |
011 [8] 11, 13, 14, 17, 35, 50, 51, 65 💬 |
89 |
Jp-1730/f01 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
90 |
Jp-1730/f02 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
91 |
Jp-1730/f03 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
92 |
L-threo dops |
Droxidopa |
[1] D01277 D01277 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
93 |
Levodopa |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
002 [8] 2 , 4 , 6 , 17, 90, 140, 164, 201 💬 |
94 |
Levodopa test |
Levodopa |
[1] D00059 D00059 💬 |
DRD1 [5] DRD1, DRD2, DRD3, DRD4, DRD5 💬 |
Alcoholism [11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway |
017 [1] 17 💬 |
95 |
Lithium carbonate |
Carbonate ion |
[1] D00801 D00801 💬 |
- |
- |
002 [6] 2 , 13, 17, 18, 19, 127 💬 |
96 |
Litio carbonato |
- |
- |
- |
- |
002 [2] 2 , 17 💬 |
97 |
Losartan |
Losartan |
[2] D00357 D00357, D08146 D08146 💬 |
AGTR1 [1] AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications [16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 [18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
98 |
Metoprolol |
Metoprolol |
[3] D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [6] 17, 57, 58, 113, 193, 226 💬 |
99 |
Metoprolol tartrate 50 mg |
Metoprolol |
[3] D00601 D00601, D02358 D02358, D05011 D05011 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
100 |
Midodrine |
Midodrine |
[2] D01307 D01307, D08220 D08220 💬 |
ADRA1A [3] ADRA1A, ADRA1B, ADRA1D 💬 |
AMPK signaling pathway [7] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
006 [3] 6 , 17, 58 💬 |
101 |
Modal |
- |
- |
- |
- |
002 [5] 2 , 6 , 17, 46, 70 💬 |
102 |
N1,n3-bis(2-mercaptoethyl) isophthalamide |
- |
- |
- |
- |
005 [2] 5 , 17 💬 |
103 |
Nbmi |
- |
- |
- |
- |
005 [2] 5 , 17 💬 |
104 |
Nebivolol |
Nebivolol |
[1] D05127 D05127 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [3] 17, 113, 167 💬 |
105 |
Nebivolol 5 mg |
Nebivolol |
[1] D05127 D05127 💬 |
ADRB1 [1] ADRB1 💬 |
Adrenergic signaling in cardiomyocytes [10] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
106 |
Nitrogen |
Nitrogen |
[1] D00083 D00083 💬 |
- |
- |
005 [6] 5 , 6 , 17, 171, 211, 299 💬 |
107 |
Normal saline |
- |
- |
- |
- |
006 [16] 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
108 |
Nt 101 |
- |
- |
- |
- |
005 [4] 5 , 6 , 7 , 17 💬 |
109 |
Other: abdominal compression |
- |
- |
- |
- |
017 [1] 17 💬 |
110 |
Other: brain mri (magnetic resonance imaging) |
- |
- |
- |
- |
017 [1] 17 💬 |
111 |
Other: sham abdominal compression |
- |
- |
- |
- |
017 [1] 17 💬 |
112 |
Procedure: brain magnetic resonance imaging (mri) |
- |
- |
- |
- |
017 [1] 17 💬 |
113 |
Procedure: determination of objective and subjective pain threshold |
- |
- |
- |
- |
017 [1] 17 💬 |
114 |
Prozac |
- |
- |
- |
- |
017 [1] 17 💬 |
115 |
Pseudoephedrine |
Pseudoephedrine |
[4] D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
116 |
Pseudoephedrine + 480 ml water |
Pseudoephedrine |
[5] D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
117 |
Pseudoephedrine + 50 ml water |
Pseudoephedrine |
[5] D00001 D00001, D00485 D00485, D05648 D05648, D05649 D05649, D08449 D08449 💬 |
ADRA1A [9] ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway [13] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
017 [1] 17 💬 |
118 |
Raclopride |
Raclopride |
- |
- |
- |
005 [4] 5 , 6 , 7 , 17 💬 |
119 |
Radiation: h215o pet |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
120 |
Radiation: pet (positron emission tomography) study |
- |
- |
- |
- |
017 [1] 17 💬 |
121 |
Rasagilina |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
122 |
Rasagilina mesilato |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
123 |
Rasagiline |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
002 [4] 2 , 5 , 6 , 17 💬 |
124 |
Rasagiline mesylate |
Rasagiline |
[3] D02562 D02562, D08469 D08469, D10829 D10829 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
125 |
Rifampicin |
Rifampicin |
[1] D00211 D00211 💬 |
- |
- |
006 [5] 6 , 17, 46, 93, 299 💬 |
126 |
Riluzole |
Riluzole |
[1] D00775 D00775 💬 |
GRIA1 [14] GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 |
Alcoholism [23] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway |
002 [8] 2 , 3 , 5 , 8 , 13, 17, 18, 206 💬 |
127 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
128 |
Safinamide |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
129 |
Safinamide methanesulfonate |
Safinamide |
[1] D10158 D10158 💬 |
MAOB [1] MAOB 💬 |
Alcoholism [14] Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism |
006 [2] 6 , 17 💬 |
130 |
Saline |
- |
- |
- |
- |
006 [10] 6 , 13, 17, 53, 67, 78, 86, 97, 168, 299 💬 |
131 |
Sildenafil25 mg |
- |
- |
- |
- |
017 [1] 17 💬 |
132 |
Sirolimus |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
006 [35] 6 , 13, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 💬 |
133 |
Sirolimus 2 mg |
Sirolimus |
[1] D00753 D00753 💬 |
MTOR [1] MTOR 💬 |
AMPK signaling pathway [50] AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
017 [1] 17 💬 |
134 |
Sunphenon egcg |
Epigallocatechin gallate |
- |
- |
- |
013 [3] 13, 17, 113 💬 |
135 |
Td-9855 |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
136 |
Tea leaf |
Tea leaf |
- |
- |
- |
017 [1] 17 💬 |
137 |
Tllsh2910 |
- |
- |
- |
- |
017 [1] 17 💬 |
138 |
Trimethaphan |
Trimethaphan |
[1] D00612 D00612 💬 |
CHRNA10 [1] CHRNA10 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
017 [1] 17 💬 |
139 |
Ubiquinol |
Ubiquinol |
- |
- |
- |
006 [3] 6 , 8 , 17 💬 |
140 |
Verdiperstat |
Verdiperstat |
[1] D11684 D11684 💬 |
MPO [1] MPO 💬 |
Acute myeloid leukemia [5] Acute myeloid leukemia, Drug metabolism - other enzymes, Neutrophil extracellular trap formation, Phagosome, Transcriptional misregulation in cancer |
002 [2] 2 , 17 💬 |
141 |
Water |
Water |
[1] D00001 D00001 💬 |
- |
- |
002 [22] 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
142 |
Xadago |
- |
- |
- |
- |
006 [2] 6 , 17 💬 |
143 |
Xeomin |
- |
- |
- |
- |
005 [7] 5 , 6 , 7 , 13, 15, 17, 113 💬 |